Ignite Creation Date:
2024-05-06 @ 6:18 PM
Last Modification Date:
2024-10-26 @ 2:45 PM
Study NCT ID:
NCT05613478
Status:
RECRUITING
Last Update Posted:
2022-11-14
First Post:
2022-11-06
Brief Title:
Camrelizumab Combined With Apatinib Mesylate and TACE in the Perioperative Treatment of Hepatocellular Carcinoma
Sponsor:
The First Affiliated Hospital with Nanjing Medical University
Organization:
The First Affiliated Hospital with Nanjing Medical University
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Preoperative |
| Hepatocellular Carcinoma |
| Immunotherapy |
Keywords: